Keywords: net, income, roche, rises, bolstered, genentech, having
Net income at Roche rises 15% in 1999, bolstered by Genentech
Article | 03 April 2000
Having earlier in the year posted strong sales growth of 12% forfull-year 1999, with revenues reaching 27.6 billion Swiss francs ($16.79 billion; Marketletter January 17), ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
